HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].

AbstractBACKGROUND:
The aim of this study was to compare the efficacy and side effects of atosiban with those of fenoterol (pulsatile administration) for acute tocolysis.
METHODS:
A prospective, open-label, randomised controlled trial was performed. Patients in preterm labour at 24+0 to 33+6 weeks of gestation were randomised to receive atosiban (A) or fenoterol (F) pulsatile administration. Primary outcome was the arrest of preterm labour.
RESULTS:
The proportion of woman remaining undelivered at 48 hours (86.3% atosiban group and 79.6% fenoterol group) and at 7 days (78.4% vs. 66.7%) was comparable. The incidence of maternal cardiovascular side effects was lower in the atosiban group (4% vs. 78%, p=0.0). Tocolysis was terminated as a result of maternal adverse effects in the fenoterol group (9%). Fetal tachycardia was lower in the atosiban group (2% vs. 22%). The mean duration of tocolytic administration was lower in the atosiban group (19 h vs. 24.5 h, p<0.05).
DISCUSSION:
The adverse effects in the pulsatile administration of fenoterol for short duration were only dependent on the initial dosage for the arrest of preterm labour. Neonatal outcome were similar between the treatment groups and were rather related to the gestational age not to the tocolytic agent.
CONCLUSIONS:
Atosiban was comparable in clinical effectiveness and was associated with fewer maternal and fetal adverse effects, so that fenoterol cannot be recommended. Completion of tocolytic therapy 12 hours after arrest of preterm labour is effective and associated with a short mean duration.
AuthorsA Nonnenmacher, H Hopp, J Dudenhausen
JournalZeitschrift fur Geburtshilfe und Neonatologie (Z Geburtshilfe Neonatol) Vol. 213 Issue 5 Pg. 201-6 (Oct 2009) ISSN: 1439-1651 [Electronic] Germany
Vernacular TitleWirksamkeit und Sicherheit von Atosiban vs. pulsatiler Applikation von Fenoterol bei der Behandlung vorzeitiger Wehen.
PMID19856243 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
CopyrightGeorg Thieme Verlag KG Stuttgart-New York.
Chemical References
  • Hormone Antagonists
  • Tocolytic Agents
  • atosiban
  • Fenoterol
  • Vasotocin
Topics
  • Adolescent
  • Adult
  • Female
  • Fenoterol (administration & dosage, adverse effects)
  • Hormone Antagonists (administration & dosage, adverse effects)
  • Humans
  • Obstetric Labor, Premature (prevention & control)
  • Pregnancy
  • Tocolytic Agents (administration & dosage, adverse effects)
  • Treatment Outcome
  • Vasotocin (administration & dosage, analogs & derivatives)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: